Peter Renehan

Peter Renehan, MD, currently serves as a Principal at Blackstone since May 2020, following a role as Senior Associate. Prior experience includes working as a Healthcare Investment Banking Associate at Lazard from August 2018 to May 2020, and a brief tenure at Flagship Pioneering in a strategy role from May 2018 to August 2018. Additionally, Peter gained experience as a Corporate Strategy Associate Intern at Moderna Therapeutics in the summer of 2017. Peter was a Fulbright Scholar from August 2012 to May 2013. Educational credentials include a Doctor of Medicine from Harvard Medical School (2013-2018), a Master of Business Administration from Harvard Business School (2016-2018), and a Bachelor's Degree in Chemistry from the College of the Holy Cross (2008-2012), along with attendance at Choate Rosemary Hall (2004-2008).